Alessandra Pavesio Company Executive

Insightful, energetic, results-oriented R&D executive with over 30 years hands-on product development experience in the biologic, cell therapy and medical device industries. Resilient, driven by a keen sense of urgency and a passion to make a difference in people’s lives, associates strategic vision and focused tactical execution to drive progress and deliver results. Proven ability to manage programs of exceptional complexity to highest standards by inspiring, empowering and mentoring highly functional and cohesive teams and effectively interacting with a network of expert advisors. Experienced in every phase of product development, from bench to bedside, including pre- and post-marketing clinical development. Combines technical knowledge and thorough understanding of regulatory and payer requirements with outside-the-box approach to compliantly expedite development programs. Passionate about enabling translation of biologic technologies into clinical practice, operates effectively across multiple communities (industry, venture capital, academia, governmental agencies, payers) to create unifying vision, obtain funding and drive progress.

Technologies: Extensive knowledge of natural biomimetic polymers and cell based therapies, with particular emphasis in orthopedics, advanced wound care, general and specialty surgery. Expert in intellectual property portfolio development.

Product development: Vast experience and proven track record of success in every phase of new product development from concept to clinical development to commercialization.

Alliance Development: Strategic negotiator of rewarding supplier and licensing agreements.

Marketing and communication- Broad experience encompassing market analysis, product specification, new product launch, collateral material development, sales training, and management of strategic relationships.

Specialties: Specialties
Translational research, product development, regenerative medicine, hyaluronan, biodegradable polymers, medical devices, cell based therapies, combination products, orthopedics, surgical implants, ENT, wound care, strategic plans, drug delivery, clinical development, product specification, project planning, market analysis new product launch, intellectual property portfolio development, supplier agreements, marketing licensing agreements, government funded project management.